Robert Ang

Robert Ang

Company: Vor Biopharma

Job title: CEO


Allogeneic Genome-Engineered HSCT Enabling Post-Transplant Targeted Therapies 3:30 pm

Concept of creating treatment-resistant stem cell transplants via gene deletion of cell surface targets Implementing next-generation allogeneic healthy donor material supply chain to GMP engineered HSC transplants Coupling genome-engineered HSCT with CAR-T and beyondRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.